Form 4: Illumina Director Receives Stock for Fees

Illumina Director Scott B. Ullem received 167 shares of common stock as payment for his board and committee fees for the second quarter of 2026.

Summary

• Scott B. Ullem, a Director at Illumina, Inc., received 167 shares of common stock on June 30, 2026.
• These shares were issued in lieu of cash compensation for his board and committee retainer fees for the second quarter of 2026.
• The number of shares was determined by dividing the cash compensation otherwise payable by the volume-weighted average closing price per share during the quarter.
• The transaction price was $149.1868 per share.
• Following this transaction, Mr. Ullem beneficially owns 11,030 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine compensation transaction for a director rather than a significant strategic or financial event.

Positives

• Director compensation is being paid in stock, aligning management's interests with shareholders.
• The transaction was executed at a price based on the volume-weighted average closing price, suggesting a fair market valuation.
• Mr. Ullem continues to hold a significant number of shares (11,030) directly.

Future Outlook

This filing does not contain forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that the use of stock awards for director compensation is a common practice in the biotechnology and life sciences sector, aiming to align executive and director interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The issuance of stock for compensation aligns director interests with shareholders, potentially promoting long-term value creation.

Key Dates

Keywords

Illumina, ILMN, Form 4, SEC Filing, Director Compensation, Stock Award, Beneficial Ownership, Securities Exchange Act